Advertisement

Melphalan/Hepatic Delivery System Beneficial for Metastatic Uveal Melanoma

0

Melphalan/HDS efficacious, has favorable risk-benefit profile for unresectable metastatic uveal melanoma

Low-to-Moderate Agreement Seen for Diagnosing Breast Cancer-Related Lymphedema

0

Breast cancer-related lymphedema diagnostic agreement moderate at best for commonly used diagnostic criteria

Prevalence of Most Cancer Risk Factors Unchanged Before, After Pandemic

0

Prevalence of smoking continued to drop during pandemic, but prevalence of excess body weight, HPV vaccination remained stable

2000 to 2021 Saw Increase in Incidence of Pancreatic Adenocarcinoma

0

Increase seen across age groups, while incidence of colorectal adenocarcinoma increased most in those aged 15 to 34 years

Federal Prosecutor Questions Medical Journals Over Alleged Bias

0
By I. Edwards HealthDay Reporter WEDNESDAY, April 23, 2025 (HealthDay News) — At least three medical journals have received letters from a top federal prosecutor...

Maternal Anemia in Early Pregnancy May Increase Risk for Congenital Heart Disease

0

Increased odds seen for giving birth to a child diagnosed with congenital heart disease within five years of birth

Patients Mainly Prefer AI as Second Reader for Screening Mammogram

0

Higher education linked to higher AI acceptance; concern for bias greater in Hispanic, non-Hispanic Black versus White participants

Infection Tied to One-Fourth of Deaths With Lower-Risk Myelodysplastic Syndromes

0

Prevalence of infections in the first year of lower-risk myelodysplastic syndromes is 7.6 percent

Durable Disease Control Possible After Stopping Immune Checkpoint Inhibitors in NSCLC

0

Predictors of longer postdiscontinuation progression-free survival include complete/partial response, longer treatment duration